𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of routine bilateral neck dissection in the management of the N0 neck in T1–T2 unilateral supraglottic cancer

✍ Scribed by Juan P. Rodrigo; Rubén Cabanillas; Virginia Franco; Carlos Suárez

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
132 KB
Volume
28
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Background. The treatment of the clinically negative (N0) neck in supraglottic laryngeal cancer continues to be an area of controversy. The aim of this study was to analyze the long-term efficacy of routine bilateral neck dissection compared with ipsilateral neck dissection in T1-T2 N0 lateral supraglottic carcinomas.

Methods. A retrospective review of 108 patients who underwent surgery for T1-T2 supraglottic squamous cell carcinoma was performed. Forty-eight had undergone ipsilateral functional neck dissection, and 60 had undergone bilateral functional neck dissections. None of these patients received adjuvant radiotherapy.

Results. No significant differences (p ¼ .78) in regional recurrence were observed between the patients treated with bilateral neck dissection (13%) and those treated with ipsilateral neck dissection (17%). The 5-year survival rates were 73% and 80% for the patients who received a bilateral and ipsilateral neck dissection, respectively (p ¼ .51).

Conclusions. This study suggests that routine bilateral neck dissection may not be necessary in the surgical treatment of all supraglottic cancers. V

📜 SIMILAR VOLUMES

Elective neck dissection for the managem
Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: Need for a randomized controlled trial
✍ Anil K. D'Cruz; Ravichand C. Siddachari; Rohan R. Walvekar; Gouri H. Pantvaidya; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 1 views

## Abstract ## Background The aim of this study is to determine the need for a randomized controlled trial in order to define the role of an elective neck dissection (END) in the treatment of early tongue cancers. ## Methods We present a large retrospective analysis of patients with T1‐2 N0 squa

Neck recurrence after level I–IV or I–II
Neck recurrence after level I–IV or I–III selective neck dissection in the management of the clinically N0 neck in patients with oral squamous cell carcinoma
✍ Mandeep S. Bajwa; Roddy McMillan; Owais Khattak; Mathew Thomas; Ojas P. Krishnan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

## Abstract ## Background Controversy remains regarding extending the level I–III selective neck dissection (SND) to include level IV in the management of the clinically N0 (cN0) neck in patients with oral squamous cell carcinoma (OSCC). ## Methods Histologic and follow‐up data of 87 patients wi

End results of a prospective trial on el
End results of a prospective trial on elective lateral neck dissection vs type III modified radical neck dissection in the management of supraglottic and transglottic carcinomas
📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

Background. Either modified type III radical neck dissection (MRND) or lateral neck dissections (LNDs) are considered valid treatments for patients with laryngeal carcinoma with clinically negative neck findings (N0). The object of this prospective study was to compare complications, neck recurrence

Prospective trial to evaluate staged nec
Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT-staged T1-2 N0 squamous cell carcinoma of the oral tongue
✍ Sinead Brennan; June Corry; Stephen Kleid; Sandro Porceddu; Kally Yuen; Danny Ri 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

## Abstract ## Background A prospective study was undertaken to evaluate a policy of selective, single‐modality elective neck treatment in T1‐2, node‐negative oral tongue squamous cell carcinoma. ## Methods Where the primary tumor showed 1 of the 4 key pathological criteria (greater than 7 mm of

Selective neck dissection in the managem
Selective neck dissection in the management of the neck after (chemo)radiotherapy for advanced head and neck cancer. Proposal for a classification update
✍ Marc Hamoir; C.René Leemans; Gilles Dolivet; Sandra Schmitz; Vincent Grégoire; G 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Abstract For patients with advanced regional disease, neck dissection following (chemo)radiotherapy remains controversial. Selective neck dissection (SND) was reported as suitable after chemoradiation in patients with advanced regional disease. Reduced morbidity represents the major advantage of